Alona is a medical technology analyst with 20-year experience in investments, in-depth analysis of medical device and pharmaceutical technologies, Innovation, Business Development and Strategy.

Formerly, Alona held the position of Director Healthcare Investments at Elron Electronic industries Ltd. (TASE:ELRAN), a leading Israel-based technology holding company. Prior to that Alona was a Managing Director at Israel Healthcare Ventures (IHCV), a fund specializing in healthcare investments where she headed the deal flow of the fund. Before that she served as Chief Operation Officer at ProSeed Biotech Services, Inc., a Boston based consulting firm, and as a Biotechnology Research Manager and ProSeed Capital Holdings CVA., Boston, MA.

In addition, Alona served as a Senior Licensing Officer at Yeda Research and Development Ltd. – the technology transfer arm of the Weizmann Institute of Science.

Alona was a Research Fellow at Harvard Medical School and at Massachusetts General Hospital.

Alona earned a Ph.D. degree in life science from the Hebrew University, M.Sc. degree from the Weizmann Institute of Science and B.Sc. from the Hebrew University.